1. Home
  2. PRME vs TREE Comparison

PRME vs TREE Comparison

Compare PRME & TREE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

HOLD

Current Price

$3.06

Market Cap

536.4M

Sector

Health Care

ML Signal

HOLD

Logo LendingTree Inc.

TREE

LendingTree Inc.

HOLD

Current Price

$31.23

Market Cap

533.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRME
TREE
Founded
2019
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
536.4M
533.1M
IPO Year
2022
2008

Fundamental Metrics

Financial Performance
Metric
PRME
TREE
Price
$3.06
$31.23
Analyst Decision
Buy
Strong Buy
Analyst Count
6
4
Target Price
$7.56
$71.25
AVG Volume (30 Days)
2.5M
447.2K
Earning Date
05-08-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
18.18
443.31
EPS
N/A
1.90
Revenue
$4,632,000.00
$1,117,324,000.00
Revenue This Year
$7.06
$19.03
Revenue Next Year
$47.01
$7.07
P/E Ratio
N/A
$16.50
Revenue Growth
55.28
24.12
52 Week Low
$2.67
$29.77
52 Week High
$6.94
$77.35

Technical Indicators

Market Signals
Indicator
PRME
TREE
Relative Strength Index (RSI) 45.78 33.00
Support Level $2.73 $29.77
Resistance Level $3.32 $39.74
Average True Range (ATR) 0.18 1.49
MACD 0.02 -0.11
Stochastic Oscillator 54.62 34.55

Price Performance

Historical Comparison
PRME
TREE

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.

About TREE LendingTree Inc.

LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.

Share on Social Networks: